Progyny Common Stock Shares Outstanding vs Net Receivables Analysis

PGNY Stock

USD 27.84 0.00 0.00%

Progyny financial indicator trend analysis is much more than just breaking down Progyny prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Progyny is a good investment. Please check the relationship between Progyny Common Stock Shares Outstanding and its Net Receivables accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Progyny. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Progyny Stock please use our How to Invest in Progyny guide.

Common Stock Shares Outstanding vs Net Receivables

Common Stock Shares Outstanding vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Progyny Common Stock Shares Outstanding account and Net Receivables. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Progyny's Common Stock Shares Outstanding and Net Receivables is 0.88. Overlapping area represents the amount of variation of Common Stock Shares Outstanding that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Progyny, assuming nothing else is changed. The correlation between historical values of Progyny's Common Stock Shares Outstanding and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Shares Outstanding of Progyny are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Common Stock Shares Outstanding i.e., Progyny's Common Stock Shares Outstanding and Net Receivables go up and down completely randomly.

Correlation Coefficient

0.88

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Net Receivables

Most indicators from Progyny's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Progyny current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Progyny. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Progyny Stock please use our How to Invest in Progyny guide.At this time, Progyny's Tax Provision is fairly stable compared to the past year. Discontinued Operations is likely to rise to about 7 M in 2024, whereas Selling General Administrative is likely to drop slightly above 59 M in 2024.

	2023	2024 (projected)
Discontinued Operations	6.6M	7.0M
Interest Income	732.6K	421.8K

Discontinued Operations Interest Income

Progyny fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Other Current Assets
Total Assets		0.9	0.27	0.9	1.0	-0.72	0.97	0.99	0.94	-0.83	0.99	0.99	0.82	0.87	0.84	0.96	-0.79	0.99	0.89	-0.79	0.8	0.9	-0.79	0.48	0.95	0.91
Short Long Term Debt Total	0.9		0.0	0.7	0.91	-0.5	0.83	0.92	0.79	-0.64	0.87	0.85	0.64	0.65	0.59	0.8	-0.89	0.95	0.67	-0.89	0.66	0.73	-0.89	0.67	0.84	0.97
Other Current Liab	0.27	0.0		0.46	0.25	-0.49	0.41	0.22	0.14	-0.6	0.19	0.34	0.6	0.43	0.41	0.21	0.19	0.18	0.48	0.19	0.55	0.45	0.19	0.09	0.44	-0.06
Total Current Liabilities	0.9	0.7	0.46		0.9	-0.74	0.92	0.88	0.85	-0.85	0.9	0.92	0.89	0.97	0.94	0.9	-0.48	0.85	0.99	-0.48	0.86	0.9	-0.48	0.43	0.9	0.71
Total Stockholder Equity	1.0	0.91	0.25	0.9		-0.72	0.97	0.99	0.93	-0.83	0.98	0.99	0.82	0.86	0.83	0.96	-0.8	0.99	0.89	-0.8	0.8	0.9	-0.8	0.51	0.95	0.91
Other Liab	-0.72	-0.5	-0.49	-0.74	-0.72		-0.81	-0.72	-0.56	0.85	-0.66	-0.74	-0.83	-0.71	-0.64	-0.67	0.41	-0.69	-0.72	0.41	-0.86	-0.78	0.41	-0.39	-0.84	-0.58
Net Tangible Assets	0.97	0.83	0.41	0.92	0.97	-0.81		0.95	0.87	-0.93	0.94	0.97	0.93	0.91	0.87	0.94	-0.67	0.94	0.92	-0.67	0.91	0.95	-0.67	0.54	0.99	0.82
Property Plant And Equipment Net	0.99	0.92	0.22	0.88	0.99	-0.72	0.95		0.9	-0.79	0.98	0.97	0.79	0.86	0.78	0.93	-0.82	0.99	0.85	-0.82	0.79	0.92	-0.82	0.48	0.94	0.93
Current Deferred Revenue	0.94	0.79	0.14	0.85	0.93	-0.56	0.87	0.9		-0.69	0.97	0.95	0.69	0.83	0.87	0.97	-0.76	0.9	0.87	-0.76	0.61	0.79	-0.76	0.28	0.82	0.82
Net Debt	-0.83	-0.64	-0.6	-0.85	-0.83	0.85	-0.93	-0.79	-0.69		-0.77	-0.84	-0.99	-0.85	-0.83	-0.8	0.42	-0.78	-0.86	0.42	-0.96	-0.88	0.42	-0.57	-0.95	-0.6
Retained Earnings	0.99	0.87	0.19	0.9	0.98	-0.66	0.94	0.98	0.97	-0.77		0.98	0.77	0.89	0.86	0.98	-0.79	0.96	0.89	-0.79	0.74	0.89	-0.79	0.38	0.9	0.89
Accounts Payable	0.99	0.85	0.34	0.92	0.99	-0.74	0.97	0.97	0.95	-0.84	0.98		0.83	0.89	0.87	0.96	-0.75	0.97	0.92	-0.75	0.8	0.91	-0.75	0.41	0.95	0.86
Cash	0.82	0.64	0.6	0.89	0.82	-0.83	0.93	0.79	0.69	-0.99	0.77	0.83		0.89	0.87	0.81	-0.37	0.77	0.9	-0.37	0.97	0.89	-0.37	0.59	0.94	0.58
Non Current Assets Total	0.87	0.65	0.43	0.97	0.86	-0.71	0.91	0.86	0.83	-0.85	0.89	0.89	0.89		0.95	0.91	-0.43	0.8	0.96	-0.43	0.87	0.94	-0.43	0.34	0.87	0.64
Non Currrent Assets Other	0.84	0.59	0.41	0.94	0.83	-0.64	0.87	0.78	0.87	-0.83	0.86	0.87	0.87	0.95		0.92	-0.39	0.75	0.97	-0.39	0.79	0.84	-0.39	0.32	0.83	0.57
Other Assets	0.96	0.8	0.21	0.9	0.96	-0.67	0.94	0.93	0.97	-0.8	0.98	0.96	0.81	0.91	0.92		-0.7	0.91	0.91	-0.7	0.75	0.89	-0.7	0.34	0.89	0.8
Long Term Debt	-0.79	-0.89	0.19	-0.48	-0.8	0.41	-0.67	-0.82	-0.76	0.42	-0.79	-0.75	-0.37	-0.43	-0.39	-0.7		-0.86	-0.45	1.0	-0.38	-0.56	1.0	-0.37	-0.66	-0.93
Cash And Short Term Investments	0.99	0.95	0.18	0.85	0.99	-0.69	0.94	0.99	0.9	-0.78	0.96	0.97	0.77	0.8	0.75	0.91	-0.86		0.83	-0.86	0.77	0.85	-0.86	0.55	0.93	0.96
Net Receivables	0.89	0.67	0.48	0.99	0.89	-0.72	0.92	0.85	0.87	-0.86	0.89	0.92	0.9	0.96	0.97	0.91	-0.45	0.83		-0.45	0.85	0.88	-0.45	0.42	0.89	0.67
Good Will	-0.79	-0.89	0.19	-0.48	-0.8	0.41	-0.67	-0.82	-0.76	0.42	-0.79	-0.75	-0.37	-0.43	-0.39	-0.7	1.0	-0.86	-0.45		-0.38	-0.56	1.0	-0.37	-0.66	-0.93
Common Stock Total Equity	0.8	0.66	0.55	0.86	0.8	-0.86	0.91	0.79	0.61	-0.96	0.74	0.8	0.97	0.87	0.79	0.75	-0.38	0.77	0.85	-0.38		0.89	-0.38	0.64	0.93	0.61
Common Stock Shares Outstanding	0.9	0.73	0.45	0.9	0.9	-0.78	0.95	0.92	0.79	-0.88	0.89	0.91	0.89	0.94	0.84	0.89	-0.56	0.85	0.88	-0.56	0.89		-0.56	0.36	0.93	0.71
Long Term Debt Total	-0.79	-0.89	0.19	-0.48	-0.8	0.41	-0.67	-0.82	-0.76	0.42	-0.79	-0.75	-0.37	-0.43	-0.39	-0.7	1.0	-0.86	-0.45	1.0	-0.38	-0.56		-0.37	-0.66	-0.93
Non Current Liabilities Total	0.48	0.67	0.09	0.43	0.51	-0.39	0.54	0.48	0.28	-0.57	0.38	0.41	0.59	0.34	0.32	0.34	-0.37	0.55	0.42	-0.37	0.64	0.36	-0.37		0.6	0.57
Capital Surpluse	0.95	0.84	0.44	0.9	0.95	-0.84	0.99	0.94	0.82	-0.95	0.9	0.95	0.94	0.87	0.83	0.89	-0.66	0.93	0.89	-0.66	0.93	0.93	-0.66	0.6		0.81
Other Current Assets	0.91	0.97	-0.06	0.71	0.91	-0.58	0.82	0.93	0.82	-0.6	0.89	0.86	0.58	0.64	0.57	0.8	-0.93	0.96	0.67	-0.93	0.61	0.71	-0.93	0.57	0.81

Click cells to compare fundamentals

Progyny Account Relationship Matchups

Progyny fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	150.4M	253.9M	358.1M	543.0M	756.6M	794.5M
Other Current Liab	16.8M	34.3M	2.2M	49.0M	1.2M	1.1M
Total Current Liabilities	36.2M	77.8M	98.8M	159.5M	186.0M	95.3M
Total Stockholder Equity	114.3M	166.9M	251.8M	377.0M	553.4M	581.1M
Net Tangible Assets	100.0M	153.9M	239.3M	365.0M	419.7M	440.7M
Property Plant And Equipment Net	3.1M	12.1M	12.8M	15.3M	27.8M	29.2M
Net Debt	(80.4M)	(62.0M)	(84.0M)	(112.4M)	(77.9M)	(81.8M)
Retained Earnings	(113.5M)	(68.2M)	(2.4M)	27.9M	90.0M	94.5M
Accounts Payable	19.4M	43.5M	61.4M	109.3M	125.4M	131.7M
Cash	80.4M	70.3M	91.4M	120.1M	97.3M	73.0M
Non Current Assets Total	18.0M	63.7M	99.5M	109.1M	116.2M	69.4M
Non Currrent Assets Other	652K	573K	2.9M	4.0M	3.4M	1.9M
Other Assets	652K	8.2M	74.2M	81.9M	94.2M	98.9M
Cash And Short Term Investments	80.4M	109.3M	119.4M	189.3M	371.1M	389.6M
Net Receivables	47.1M	75.7M	134.6M	240.1M	241.9M	121.6M
Common Stock Shares Outstanding	83.6M	99.1M	100.4M	100.0M	100.7M	101.6M
Liabilities And Stockholders Equity	150.4M	253.9M	358.1M	543.0M	756.6M	794.5M
Non Current Liabilities Total	19.4M	9.2M	7.4M	6.5M	17.2M	10.4M
Capital Surpluse	228.8M	236.1M	255.3M	349.5M	402.0M	422.1M
Other Current Assets	5.0M	5.3M	4.6M	4.5M	27.5M	28.8M
Other Stockholder Equity	227.7M	235.1M	254.3M	348.5M	460.6M	242.6M
Total Liab	36.2M	87.0M	106.2M	166.0M	203.2M	102.6M
Net Invested Capital	114.3M	166.9M	251.8M	377.0M	553.4M	581.1M
Property Plant And Equipment Gross	3.1M	12.1M	12.8M	15.3M	33.1M	34.8M
Total Current Assets	132.4M	190.2M	258.5M	433.9M	640.4M	672.4M
Accumulated Other Comprehensive Income	(150.4M)	1K	(93K)	501K	2.8M	3.0M
Net Working Capital	96.3M	112.4M	159.7M	274.3M	454.5M	477.2M
Intangible Assets	2.4M	1.2M	599K	99K	89.1K	84.6K
Property Plant Equipment	3.1M	3.4M	12.8M	8.4M	9.6M	5.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

VWITX	Vanguard Intermediate Term Tax Exempt
VGSTX	Vanguard Star Fund
VFIAX	Vanguard 500 Index

When determining whether Progyny offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Progyny's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Progyny Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Progyny Stock:

How To Invest In Progyny

Details

Is Progyny Stock a good investment?

Details

What is Progyny's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Progyny. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Progyny Stock please use our How to Invest in Progyny guide.

You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Progyny Stock analysis

When running Progyny's price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.

	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Stocks Directory Find actively traded stocks across global markets
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities

Is Progyny's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Progyny. If investors know Progyny will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Progyny listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.06)

Earnings Share

0.61

Revenue Per Share

11.583

Quarterly Revenue Growth

0.076

Return On Assets

0.0569

The market value of Progyny is measured differently than its book value, which is the value of Progyny that is recorded on the company's balance sheet. Investors also form their own opinion of Progyny's value that differs from its market value or its book value, called intrinsic value, which is Progyny's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Progyny's market value can be influenced by many factors that don't directly affect Progyny's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Progyny's value and its price as these two are different measures arrived at by different means. Investors typically determine if Progyny is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Progyny's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Progyny Common Stock Shares Outstanding vs Net Receivables Analysis

Common Stock Shares Outstanding vs Net Receivables

Common Stock Shares Outstanding vs Net Receivables Correlation Analysis

Correlation Coefficient

Common Stock Shares Outstanding

Net Receivables

Progyny fundamental ratios Correlations

Progyny Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Progyny fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Progyny Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Good Will	+ 1.0	Long Term Debt
Long Term Debt Total	+ 1.0	Long Term Debt
Long Term Debt Total	+ 1.0	Good Will
Property Plant And Equipment Net	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Assets

Cash	- 0.99	Net Debt
Common Stock Total Equity	- 0.96	Net Debt
Capital Surpluse	- 0.95	Net Debt
Other Current Assets	- 0.93	Long Term Debt Total
Other Current Assets	- 0.93	Good Will
Other Current Assets	- 0.93	Long Term Debt